On Friday 29 April, the US National Academy of Sciences and US National Academy of Medicine’s Committee on Human Gene Editing will hold an information-gathering meeting in Paris, France, focusing on principles underlying human gene editing governance and policy. This is not intended to be a comprehensive 'International Summit 2.0', rather it will be a meeting of the consensus study committee as part of the process of developing its report. The meeting will take place at the French National Academy of Medicine, 16 Rue Bonaparte. Those interested in attending the NAS/NAM sessions on 29 April are most welcome. Because space is limited, please register using this registration link. If you will be representing an academy of sciences or academy of medicine, please indicate “yes” for #2 (that you are associated with the meeting) and specify which academy. For those unable to attend in person, the sessions will also be webcast.
Further details on the agenda, speakers, and webcast availability will be announced soon at www.nationalacademies.org/gene-editing/consensus-study.
The day before, on Thursday 28 April, a number of European academies are organizing a workshop on the European landscape for human genome editing. The meeting will also be held at the French Academy of Medicine, and will include representatives from academia, funding agencies, industry, regulators and the wider European authorities. This meeting is being jointly organized by the Federation of European Academies of Medicine (FEAM), the UK Academy of Medical Sciences and the French Academy of Medicine, with support from the InterAcademy Partnership for Health and the French Academy Foundation. Those wishing to attend the sessions on 28 April are asked to please email Rachel Brown at the UK Academy of Medical Sciences (email@example.com).